Description:
Isavuconazole is a new triazole currently undergoing phase III clinical trials. This compound has shown in vitro activity against a large number of clinical important yeasts and molds including Aspergillus spp., Fusarium spp., Scedosporium spp., Candida spp., the Zygomycetes and Cryptococcus spp.
- Molecular Weight: 437.47
- Molecular Formula: C22H17F2N5OS
Purity: >98%
Canonical SMILES:
CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O
InChI:
InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-8-17(23)6-7-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1
InChIKey: DDFOUSQFMYRUQK-RCDICMHDSA-N
- Application: Antifungal Agents
Synonyms:
BAL4815; BAL-4815; BAL 4815; RO 0094815; RO-0094815; RO0094815; Cresemba
More details are to be found on supplier website
